Stage IVA Squamous Cell Carcinoma of the Oropharynx Completed Phase 1 Trials for Cisplatin (DB00515)

IndicationStatusPhase
DBCOND0029848 (Stage IVA Squamous Cell Carcinoma of the Oropharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02035527Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckTreatment